Startech makes Texas Emerging Technology Fund investment in ViroXis
The award is to advance the product development and commercialisation of its topical Albuterpenoid drug, a patented anti-viral therapeutic derived from East Indian Sandalwood oil (EISO), aimed at
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.